After Medical School at SUNY Medical Center in Brooklyn, New York and Residency in Pediatrics at New York Hospital-Cornell Medical Center, I moved to the Bay Area for a Fellowship in clinical and molecular Pediatric Endocrinology at the University of California, San Francisco (UCSF).
My first position in industry was directly related to my specialty training. Shortly after completing my Fellowship program, I was recruited by Syntex Research, a pharmaceutical company in Palo Alto, California, to work on a development program for a gonadotropin-releasing hormone agonist (GnRH agonist) to treat precocious puberty in children. I worked as an Associate Medical Director, becoming part of a research group responsible for clinical studies for reproductive indications, antiviral therapy, rheumatology, and dermatology. It was a great entry to clinical research, a chance to learn to collaborate with other pharmaceutical physicians and to learn how to interact with biostatisticians, data managers, and clinical research associates.
Since then, I have had the opportunity to work on projects in a wide variety of therapeutic areas. I have been an employee, of both pharmaceutical companies and clinical research organizations, as well as a contractor to many Bay Area pharmaceutical and biotech companies. During my career so far, I have served as the medical monitor for Phase 1, Phase 2, Phase 3 and Phase 4 clinical studies for indications as diverse as dermatology, incontinence, cardiology, peripheral vascular disease, and organ transplantation. I even served as the PI for some Phase 1 studies, allowing me to have experience of both sides of the clinical trials spectrum. I have worked in Clinical Research and Medical Affairs. In addition, I have contributed to INDs, NDAs, MAAs (see the Abbreviations section for a lexicon of Pharmaceutical Industry abbreviations).
Like Bernadette, I still work as an independent consultant. Most recently, I have worked on Pharmacovigilance projects, reviewing safety reports and writing Serious Adverse Event Reports for several companies, as well as serving as the medical monitor for clinical trials.
My first position in industry was directly related to my specialty training. Shortly after completing my Fellowship program, I was recruited by Syntex Research, a pharmaceutical company in Palo Alto, California, to work on a development program for a gonadotropin-releasing hormone agonist (GnRH agonist) to treat precocious puberty in children. I worked as an Associate Medical Director, becoming part of a research group responsible for clinical studies for reproductive indications, antiviral therapy, rheumatology, and dermatology. It was a great entry to clinical research, a chance to learn to collaborate with other pharmaceutical physicians and to learn how to interact with biostatisticians, data managers, and clinical research associates.
Since then, I have had the opportunity to work on projects in a wide variety of therapeutic areas. I have been an employee, of both pharmaceutical companies and clinical research organizations, as well as a contractor to many Bay Area pharmaceutical and biotech companies. During my career so far, I have served as the medical monitor for Phase 1, Phase 2, Phase 3 and Phase 4 clinical studies for indications as diverse as dermatology, incontinence, cardiology, peripheral vascular disease, and organ transplantation. I even served as the PI for some Phase 1 studies, allowing me to have experience of both sides of the clinical trials spectrum. I have worked in Clinical Research and Medical Affairs. In addition, I have contributed to INDs, NDAs, MAAs (see the Abbreviations section for a lexicon of Pharmaceutical Industry abbreviations).
Like Bernadette, I still work as an independent consultant. Most recently, I have worked on Pharmacovigilance projects, reviewing safety reports and writing Serious Adverse Event Reports for several companies, as well as serving as the medical monitor for clinical trials.
